Patent intelligence · US
US 9091701
Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cho…
Patent details — US 9091701
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 28, 2015
- Expiration
- Jul 23, 2035
- Claims
- 33
- CPC classes
- A61K, A61K31/575
Quick answer
US 9091701 (Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis) is held by The Regents of the University of Colorado, a Body Corporate. Status: granted. Granted Jul 28, 2015. Expires Jul 23, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 33
- CPC classes
- A61K, A61K31/575
More from The Regents of the University of Colorado, a Body Corporate
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 9091701?
US 9091701 (Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis) is held by The Regents of the University of Colorado, a Body Corporate. Status: granted. Granted Jul 28, 2015. Expires Jul 23, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9091701?
The Regents of the University of Colorado, a Body Corporate is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 9091701 expire?
Our index shows an expiration date of Jul 23, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.